The Ki-67 expression was gradually elevated with glioma grade, and the GBM had the highest Ki-67 expression, however, there was no association between the IDH1 mutation or 1p19q codeletion status and Ki-67 expression. Here, IDH1 is linked to central nervous system cancer.